|
|
(1 of 2) Florida Minority Cancer Research & Training Center: Feasibility Studies
|
5P20CA192990-02
|
$171,681
|
$103,009
|
REAMS, ROMONIA
|
FLORIDA AGRICULTURAL AND MECHANICAL UNIV
|
|
|
(2/2) CDU/UCLA Cancer Center Partnership to Eliminate Cancer Health Disparities
|
2U54CA143930-06
|
$504,604
|
$80,737
|
FARIAS-EISNER, ROBIN
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
|
(PQ3) AGEs and Race Specific Tumor Immune Response in Prostate Cancer
|
1R21CA194469-01
|
$140,445
|
$140,445
|
TURNER, DAVID
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
|
(PQA1) Novel epigenetic mechanism mediate metformin inhibition of prostate cancer
|
5R01CA180277-03
|
$276,937
|
$276,937
|
LI, XIN
|
NEW YORK UNIVERSITY
|
|
|
(PQC-5) Zwitterionic NIR/Zr-89 Agents for Prostate Cancer Staging and Treatment
|
5R01CA185457-02
|
$1,143,340
|
$1,143,340
|
FRANGIONI, JOHN
|
CURADEL, LLC
|
|
|
(PQC3) Using an Immunoscore to Assess Tumor-medicated Immune Variations in Africa
|
5R21CA190076-02
|
$152,685
|
$152,685
|
WALLACE, TIMOTHY
|
BON SECOURS RICHMOND COMMUNITY HOSPITAL
|
|
|
(PQC4) Habitats in Prostate Cancer
|
5R01CA190105-02
|
$692,000
|
$692,000
|
GILLIES, ROBERT
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
|
(PQD-1) Selective pressure of antiandrogens on castration resistant prostate canc
|
5R01CA185509-02
|
$258,128
|
$258,128
|
GHOSH, PARAMITA
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
|
1/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership
|
5P20CA192973-02
|
$191,836
|
$95,918
|
MANNE, UPENDER
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
|
2/2 Florida Minority Cancer Research & Training Center: Feasibility Studies
|
5P20CA192992-02
|
$167,750
|
$117,425
|
ODEDINA, FOLAKEMI
|
UNIVERSITY OF FLORIDA
|
|
|
2/2 NCCU-LCCC Partnership in Cancer Research
|
2U54CA156733-06
|
$1,002,966
|
$20,059
|
EARP, HENRY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
|
2/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership
|
5P20CA192976-02
|
$144,556
|
$67,941
|
MISHRA, MANOJ
|
ALABAMA STATE UNIVERSITY
|
|
|
2015 Hormone-Dependent Cancers Gordon Research Conference and Gordon Research Sem
|
1R13CA195982-01
|
$5,000
|
$2,500
|
SIKORA, MATTHEW
|
GORDON RESEARCH CONFERENCES
|
|
|
4C and Genome Editing for Causal SNP and Gene Discovery at Cancer Risk Loci
|
1R21CA191725-01A1
|
$223,181
|
$73,650
|
FREEDMAN, MATTHEW
|
DANA-FARBER CANCER INST
|
|
|
A Dietary Supplement As Adjunct Therapy In Castration-Resistant Prostate Cancer
|
1R41CA186498-01A1
|
$160,996
|
$160,996
|
WU, DAQING
|
METCURE THERAPEUTICS, LLC
|
|
|
A Mitogen-induced G Protein-coupled Receptor
|
ZIA SC 009389
|
$110,957
|
$55,479
|
Kelly Siebenlist, Kathleen
|
CCR (NCI)
|
|
|
A MULTILEVEL APPROACH TO ENERGY BALANCE AND CANCER ACROSS THE LIFECOURSE
|
5U54CA155496-05
|
$1,739,060
|
$486,937
|
COLDITZ, GRAHAM
|
WASHINGTON UNIVERSITY
|
|
|
A Network Analytic Approach to Modeling Variation in Prostate Cancer Care
|
5K07CA151910-05
|
$156,570
|
$156,570
|
POLLACK, CRAIG
|
JOHNS HOPKINS UNIVERSITY
|
|
|
A New Mechanism for Castration Resistant Prostate Cancer
|
5R01CA166894-03
|
$369,879
|
$369,879
|
SUN, ZIJIE
|
STANFORD UNIVERSITY
|
|
|
A new regulator for Wnt/beta-catenin signaling and prostate tumorigenesis
|
5R01CA151623-05
|
$337,566
|
$337,566
|
SUN, ZIJIE
|
STANFORD UNIVERSITY
|
|
|
A novel strategy to identify prostate cancer biomarkers for patient management
|
5R01CA172603-03
|
$319,550
|
$319,550
|
HUANG, JIAOTI
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
|
A Novel Therapeutic Approach for Primary and Metastatic Prostate Cancer
|
5R01CA150182-05
|
$292,333
|
$292,333
|
AHMED, KHALIL
|
UNIVERSITY OF MINNESOTA
|
|
|
A progressive cone-beam CT dose control scheme for image-guided radiation therapy
|
5R21CA178787-02
|
$207,495
|
$103,748
|
JIA, XUN
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
|
A Randomized Clinical Trial of Exercise for Men with Metastatic Prostate Cancer
|
1R21CA184605-01A1
|
$172,369
|
$172,369
|
KENFIELD, STACEY
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
|
A Systems Biology Approach to the Development of Cancer Biomarkers
|
3U01CA111275-10S1
|
$163,530
|
$163,530
|
CHINNAIYAN, ARUL
|
UNIVERSITY OF MICHIGAN
|
|
|
A+PSA Assay for Improved Prostate Cancer Diagnosis and Risk Assessment
|
5R01CA164388-04
|
$319,550
|
$319,550
|
ZENG, GANG
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196 - 03152
|
$1,131,149
|
$56,557
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-39S1
|
$62,498
|
$1,875
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-39S2
|
$125,000
|
$3,750
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-39
|
$7,704,373
|
$231,131
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
ACN-12011-001-00003 09/20/2015- 09-30-2015 FOR NCI DETECTION NETWORK REFERENCE LA
|
ACN12011001
|
$459,666
|
$459,666
|
UNKNOWN, UNKNOWN
|
UNIFORM THE SERVICES UNIVERSITY OF THE H
|
|
|
ACN15001-001-0000 STUDY OF NUTRIENT-GENE INTERACTIONS (ERX/AHR) 3/ARS NO. 60-123
|
ACN15001001
|
$65,000
|
$65,000
|
UNKNOWN, UNKNOWN
|
UNITED STATES DEPT OF AGRICULTURE
|
|
|
ACN15005-001-00000 - NCI EARLY DETECTION RESEARCH NETWORK: BIOMARKER STANDARDIZAT
|
ACN15005001
|
$600,000
|
$600,000
|
UNKNOWN, UNKNOWN
|
NATIONAL INSTITUTE OF STANDARDS & TECHNO
|
|
|
Activatable molecular cancer imaging probe
|
ZIA BC 011512
|
$114,070
|
$22,814
|
Kobayashi, Hisataka
|
CCR (NCI)
|
|
|
Advancement and Validation of Prostate Diffusion and Spectroscopic MRI
|
5R01CA160902-04
|
$156,154
|
$156,154
|
MAIER, STEPHAN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Aggressive Prostate Cancer: Linking Epigenomics and Genetics for Prevention
|
5K05CA175147-02
|
$88,959
|
$88,959
|
STANFORD, JANET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
Agricultural Cohort Consortium
|
ZIA CP010119 - 10537
|
$74,872
|
$7,487
|
Beane Freeman, Laura
|
DCEG (NCI)
|
|
|
Akt isoform-specific signaling in breast cancer metastasis
|
5R00CA157945-04
|
$245,350
|
$61,338
|
CHIN, YUET MING REBECCA
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-02S1
|
$34,176
|
$2,051
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-02S2
|
$810,357
|
$48,621
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
5U10CA180821-02
|
$9,967,453
|
$598,047
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
An Androgen-Regulated Cytokine Network Controls Prostate Apoptosis.
|
7R01CA151753-05
|
$333,996
|
$333,996
|
KROLEWSKI, JOHN
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
|
An inevitable mechanism of resistance to androgen-directed therapy
|
5R01CA188609-02
|
$312,288
|
$312,288
|
DONG, YAN
|
TULANE UNIVERSITY OF LOUISIANA
|
|
|
An integrated approach to dissect the functional network of large non-coding RNA
|
4R00CA175290-03
|
$249,000
|
$249,000
|
CHEN, YIWEN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
|
Analyses of human T regulatory cells
|
ZIA BC 010973
|
$416,154
|
$124,846
|
Tsang, Kwong
|
CCR (NCI)
|
|
|
Androgen Receptor Action in Castration Resistant Prostate Cancer
|
5P01CA163227-03
|
$2,055,706
|
$2,055,706
|
BALK, STEVEN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Androgen Receptor- and Myc-Mediated Glutamine Metabolism in Prostate Cancer
|
1R21CA191009-01
|
$202,459
|
$202,459
|
FRIGO, DANIEL
|
UNIVERSITY OF HOUSTON
|
|
|
Androgen Signaling in prostate cancer progression and CRPC development
|
5R01CA070297-16
|
$299,564
|
$299,564
|
SUN, ZIJIE
|
STANFORD UNIVERSITY
|
|
|
Angiogenin-Induced RNA Cleavage in Cancer
|
5R01CA168872-03
|
$357,689
|
$178,845
|
ANDERSON, PAUL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Annotating Oncogene Status in Prostate Cancer with Zr-89-transferrin PET
|
3R01CA176671-03S1
|
$67,007
|
$67,007
|
LEWIS, JASON
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Total relevant funding to Prostate for this search: $228,871,655
|
